ITM AG: ITM to Host Virtual Symposium on New Approaches for Targeted Radionuclide Therapy in Precision Oncology with Key Opinion Leaders on Friday, June 4th, 2021 in Parallel to 2021 ASCO Annual Meeting
(0) ITM AG, a leading radiopharmaceutical company, today announced that it will host a virtual symposium titled, "New Approaches for Targeted Radionuclide Therapy in Precision Oncology" as an ancillary event in parallel to the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The symposium will feature renowned key opinion leaders in the field and will be held on Friday, June 4 th, 2021 from 9.30 am 11.00 am ET 3.30 pm 5.00 pm CEST. The interactive live-session will explore the latest science and clinical practices driving Targeted Radionuclide Therapy to the forefront of ...